High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial
- PMID: 30882477
- DOI: 10.1097/CCM.0000000000003740
High-Flow Oxygen Therapy After Noninvasive Ventilation Interruption in Patients Recovering From Hypercapnic Acute Respiratory Failure: A Physiological Crossover Trial
Abstract
Objectives: Assessing gas exchange, diaphragm function, respiratory rate, and patient comfort during high-flow oxygen therapy and standard oxygen at the time of noninvasive ventilation discontinuation.
Design: Randomized crossover physiologic study.
Setting: Two ICUs.
Patients: Thirty chronic obstructive pulmonary disease patients with hypercapnic acute respiratory failure receiving noninvasive ventilation greater than 24 hours.
Interventions: All patients underwent five 30-minute trials, the first, third, and fifth trial in noninvasive ventilation, whereas the second and fourth were randomly conducted with either standard oxygen and high-flow oxygen therapy.
Measurements and main results: Diaphragm displacement and thickening fraction were determined by sonographic evaluation at the end of each trial. Arterial blood gases, respiratory rate, and patient comfort were also assessed. PaCO2 (p = 0.153) and pH (p = 0.114) were not different among trials, while PaO2 was greater in noninvasive ventilation than with both standard oxygen (p ≤ 0.005) and high-flow oxygen therapy (p ≤ 0.001). The diaphragm displacement was no different among trials (p = 0.875), while its thickening fraction was greater with standard oxygen, compared with high-flow oxygen therapy and all noninvasive ventilation trials (p < 0.001 for all comparisons), without differences between high-flow oxygen therapy and noninvasive ventilation. Respiratory rate also increased with standard oxygen, compared with both high-flow oxygen therapy (p < 0.001) and noninvasive ventilation (p < 0.01). High-flow oxygen therapy improved comfort, compared with standard oxygen (p = 0.004) and noninvasive ventilation (p < 0.001).
Conclusions: At the time of noninvasive ventilation interruption, PaCO2 and diaphragm displacement remained unchanged regardless of the modality of oxygen administration. However, although standard oxygen resulted in a remarkable increase in diaphragm thickening fraction, high-flow oxygen therapy allowed maintaining it unchanged, while improving patient comfort.
Comment in
-
High Flow Versus Standard Oxygen Therapy After Noninvasive Ventilation Withdrawal.Crit Care Med. 2019 Oct;47(10):e846-e847. doi: 10.1097/CCM.0000000000003864. Crit Care Med. 2019. PMID: 31524707 No abstract available.
-
The authors reply.Crit Care Med. 2019 Oct;47(10):e847-e848. doi: 10.1097/CCM.0000000000003936. Crit Care Med. 2019. PMID: 31524708 No abstract available.
-
Can High-Flow Oxygen Overstep Low-Flow Oxygen Therapy in Weaning From Noninvasive Ventilation in Patients With Acute Respiratory Failure Due to Chronic Obstructive Pulmonary Disease Exacerbation?Crit Care Med. 2020 Jan;48(1):e76. doi: 10.1097/CCM.0000000000004040. Crit Care Med. 2020. PMID: 31833988 No abstract available.
-
The authors reply.Crit Care Med. 2020 Jan;48(1):e76-e77. doi: 10.1097/CCM.0000000000004085. Crit Care Med. 2020. PMID: 31833989 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical